Antiplatelet Therapy Considerations in Women
Coronary artery disease (CAD) is the leading cause of death worldwide, but because of several factors, one of which is antiplatelet therapy, the mortality rates have steadily declined. However, women continue to experience higher CAD mortality rates than men. This may be explained by differences in...
Main Authors: | Khadeeja Esmail, MD, Dominick J. Angiolillo, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript
2019-02-01
|
Series: | Cardiovascular Innovations and Applications |
Subjects: | |
Online Access: | https://www.ingentaconnect.com/content/cscript/cvia/2019/00000003/00000004/art00004 |
Similar Items
-
Change of Platelet Reactivity to Antiplatelet Therapy after Stenting Procedure for Cerebral Artery Stenosis: VerifyNow Antiplatelet Assay before and after Stenting
by: Deok Hee Lee, et al.
Published: (2012-02-01) -
Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
by: Hamzah Khan, et al.
Published: (2020-10-01) -
Dual antiplatelet therapy in ischemic stroke
by: Birsen İnce
Published: (2019-08-01) -
Antiplatelet therapy strategies for ischemic stroke
by: M. Yu. Maksimova, et al.
Published: (2017-07-01) -
INDIVIDUAL ANTIPLATELET THERAPY IN PATIENTS WITH ATHEROSCLEROSIS OF LOWER EXTREMITIES: MYTH OR REALITY?
by: O. V. Sirotkina, et al.
Published: (2018-01-01)